Lotus Bio-Technology Development Corp. (LBTD)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | -17.75 Thousand |
| Net Income | - | - | - | - | - | -781.1 Thousand |
| Depreciation & Amortization | - | - | - | - | - | 1092.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | 765 Thousand |
| Change in working capital | - | - | - | - | - | 15.01 Thousand |
| Other non-cash items | - | - | - | - | - | 5458.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | -1500.00 |
| Debt repayment | - | - | - | - | - | -6450.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | -1500.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | -3663.00 |
| Cash at beginning of period | - | - | - | - | - | 1505.00 |
| Cash at end of period | - | - | - | - | - | 5.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | -1500.00 |
| Free Cash Flow | - | - | - | - | - | -17.75 Thousand |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | - | - | - | - | -7291.00 |
| Depreciation & Amortization | - | - | - | - | - | 1638.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | 1159.00 |
| Other non-cash items | - | - | - | - | - | -15 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | 19.49 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 19.49 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | - | - | - | 1.00 |
| Cash at end of period | - | - | - | - | - | 1.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | -19.49 Thousand |
ENJ
UVA
002487
COV
RTNINDIA
688418